Gonadotropin-Releasing Hormone Analogues in the Treatment of Sickle Cell Anemia-Associated Priapism
- 1 August 1993
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 150 (2 Part 1) , 475-477
- https://doi.org/10.1016/s0022-5347(17)35520-9
Abstract
Priapism secondary to sickle cell anemia has been treated with a variety of therapeutic regimens. Recurrent sickle cell priapism is common and in many cases results when detumescence has not been achieved reliably. We report on a patient with sickle cell disease and recurrent priapism who was treated successfully for more than a year with monthly gonadotropin-releasing hormone analogue therapy after failure of standard medical management.Keywords
This publication has 8 references indexed in Scilit:
- Priapism Associated With the Sickle Cell Hemoglobinopathies: Prevalence, Natural History and SequelaeJournal of Urology, 1991
- Priapism as a Complication of Sickle Cell DiseaseJournal of Urology, 1991
- STILBOESTROL AND STUTTERING PRIAPISM IN HOMOZYGOUS SICKLE-CELL DISEASEThe Lancet, 1985
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Automated Erythrocytopheresis for Relief of Priapism in Sickle Cell HemoglobinopathiesJournal of Urology, 1983
- Changing Surgical Concepts in the Treatment of PriapismJournal of Urology, 1981
- The Management of Priapism in Sickle Cell AnemiaJournal of Urology, 1978
- Priapism: Evaluation of Treatment RegimensJournal of Urology, 1974